ANALYZE THE DIRECT MEDICAL COSTS IN THE TREATMENT OF VENUE THROMBOSIS AT SOME SPECIALIZED HOSPITALS IN VIETNAM WITHIN 2019-2022

Cát Đông Trần1, Mạnh Hùng Phạm2, Minh Trạng Bùi3, Cao Đức Huy Nguyễn1, Tuấn Minh Lê2, Chí Thanh Nguyễn3, Thị Thu Thủy Nguyễn4,
1 HTARI
2 Bach Mai hospital
3 CMI
4 HIU

Main Article Content

Abstract

Venous thromboembolism (VTE) has a high incidence, especially in the elderly population. This contributes to an increased economic burden on the aging population of Vietnam. Currently, in Vietnam, the cost analysis of VTE treatment has not been fully studied. A cross-sectional descriptive study has been conducted on the research sample including VTE treatment sessions in the period of 2019 - 2022 at the Heart Institute of Ho Chi Minh City and the Cardiology Institute - Bach Mai hospital to analyze the medical cost of VTE treatment. Studying 98 patients with 160 courses of VTE treatment recorded an average treatment cost of 1,499,583 VND (95% CI: 1,169,722 - 1,829,444 VND) for one outpatient treatment session and 15,185,660 VND (95% CI: 11,711,797-18,659,523 VND) for one course of inpatient treatment. For the treatment sessions using health insurance, the costs paid by the patients are higher than those paid by health insurance in both outpatient and inpatient treatment (62.47%; 54.78% respectively). The study results provided basic information on the direct medical costs of treating venous thromboembolism at 2 major

Article Details

References

1. Fernandez, M. M. và các cộng sự. (2015), "Review of the cost of venous thromboembolism", Clinicoecon Outcomes Res. 7, tr. 451-62.
2. Gussoni, G. và các cộng sự. (2013), "Real-world economic burden of venous thromboembolism and antithrombotic prophylaxis in medical inpatients", Thromb Res. 131(1), tr. 17-23.
3. Bùi Mỹ Hạnh và các cộng sự. (2019), "Chi phí điều trị trực tiếp do biến chứng huyết khối tĩnh mạch 90 ngày sau phẫu thuật", Tạp chí nghiên cứu y học.
4. Bullano, Michael F và các cộng sự. (2005), "Longitudinal evaluation of health plan cost per venous thromboembolism or bleed event in patients with a prior venous thromboembolism event during hospitalization", Journal of Managed Care Pharmacy. 11(8), tr. 663-673.
5. Galeandro, Aldo Innocente và các cộng sự. (2012), "Doppler ultrasound venous mapping of the lower limbs", Vascular Health and Risk Management. 8, tr. 59.
6. Khan, Faizan và các cộng sự. (2021), "Venous thromboembolism", The lancet. 398(10294), tr. 64-77.
7. Mahan, Charles E và các cộng sự. (2012), "Venous thromboembolism: annualised United States models for total, hospital-acquired and preventable costs utilising long-term attack rates", Thrombosis and haemostasis. 108(08), tr. 291-302.
8. Raskob, GE và các cộng sự. (2014), "ISTH Steering Committee for World Thrombosis Day", Thrombosis: a major contributor to global disease burden. Arterioscler Thromb Vasc Biol. 34(11), tr. 2363-2371.
9. Spyropoulos, Alex C và Lin, Jay (2007), "Direct medical costs of venous thromboembolism and subsequent hospital readmission rates: an administrative claims analysis from 30 managed care organizations", Journal of Managed Care Pharmacy. 13(6), tr. 475-486.
10. UNFPA Việt Nam và Nguyen Minh Duc, "Già hóa dân số và người cao tuổi ở Việt Nam".